These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4053130)

  • 1. Radioisotopic renal function studies in essential hypertension.
    Britton KE
    Cardiology; 1985; 72 Suppl 1():22-9. PubMed ID: 4053130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of antihypertensive therapy on renal function.
    Frei U; Schindler R; Koch KM
    Clin Investig; 1992; 70 Suppl 1():S120-6. PubMed ID: 1591504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of inadequate response to antihypertensive drugs. Volume factors.
    Dustan HP
    Hypertension; 1983; 5(5 Pt 2):III26-30. PubMed ID: 6629459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hemodynamic changes induced by hypertension and its treatment.
    Pessina AC; Semplicini A; Palatini P; Samà B; Mozzato MG; Rossi GP; Casiglia E
    Am J Hypertens; 1989 Feb; 2(2 Pt 2):77S-81S. PubMed ID: 2645911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of the angiotensin-converting enzyme--effect on kidney function and electrolyte balance].
    Kramer HJ
    Z Kardiol; 1988; 77 Suppl 3():39-45. PubMed ID: 3062959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ramipril, a new angiotensin-converting enzyme inhibitor on cortical nephron flow and effective renal plasma flow in patients with essential hypertension.
    al-Nahhas AM; Nimmon CC; Britton KE; Carroll MJ; al-Janabi MA; Solanki K; Bomanji J
    Nephron; 1990; 54(1):47-52. PubMed ID: 2136939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.
    Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Gotoh A; Uchida K; Higaki J
    Clin Exp Hypertens; 2006 Jul; 28(5):451-61. PubMed ID: 16820342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total and intrarenal flow distribution in healthy subjects: technique, acute effects of ibopamine and of indoramin.
    Britton KE; Nawaz MK; Nimmon CC; Mlodkowska E; Carroll M; Horne T; Granowska M
    Nephron; 1986; 43(4):265-73. PubMed ID: 3736737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurohumoral mechanisms regulating renal blood circulation in patients with hypertension undergoing captopril block of angiotensin-converting enzyme].
    Almazov VA; Ametov AS; Shliakhto EV; Dolgova IB; Pushkarev AA
    Ter Arkh; 1989; 61(8):13-5. PubMed ID: 2573961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilators, antihypertensive therapy, and the kidney.
    Hollenberg NK
    Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac output distribution and intrarenal haemodynamics: role of thromboxanes.
    Hably C; Menz V; Bartha J
    Acta Physiol Hung; 1991; 78(1):89-98. PubMed ID: 1763653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA; Geyskes GG; Dorhout Mees EJ
    Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent knowledge in the pathophysiology, pathogenesis and hemodynamics of arterial hypertension as a base for scientifically founded diagnosis and therapy].
    Wedler B
    Z Arztl Fortbild (Jena); 1984; 78(24):1011-8. PubMed ID: 6528646
    [No Abstract]   [Full Text] [Related]  

  • 16. A non-invasive gamma-camera technique for the measurement of intrarenal flow distribution in man.
    Gruenewald SM; Nimmon CC; Nawaz MK; Britton KE
    Clin Sci (Lond); 1981 Oct; 61(4):385-9. PubMed ID: 7285491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antihypertensive therapy on renal function.
    Rappelli A; Baldinelli A; Zingaretti O; Espinosa E; Salvi S; Fulgheri PD
    J Hypertens Suppl; 1991 Dec; 9(3):S37-40. PubMed ID: 1686783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validation of antihypertensive therapy from the viewpoint of kidney participation in water-salt metabolism].
    Pir'ova B
    Eksp Med Morfol; 1988; 27(4):51-8. PubMed ID: 3234312
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal vascular resistance in essential hypertension: duplex-Doppler ultrasonographic evaluation.
    Galesić K; Brkljacić B; Sabljar-Matovinović M; Morović-Vergles J; Cvitković-Kuzmić A; Bozikov V
    Angiology; 2000 Aug; 51(8):667-75. PubMed ID: 10959519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.